Vaxgen was sold for $18 million and dropping. With OXGN's price down to $1.16 and falling steadily since the announcement, shareholders are are getting the short end of the stick. Directors looking out for their interests by receiving directorships with the acquiring company is questionable when giving a company away at fire sale prices. Will they receive outsized option grants upon becoming members of OXGN's BOD? A little quid pro quo?

As much as I despise the thought of a lawsuit and the negative effect it will have on the owners, I would love to see the BOD be personally liable for damages. Their conduct is very suspect.